Caprock Group, Inc. Insulet Corp Transaction History

Caprock Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$212.22 - $313.46 $184,206 - $272,083	868 New	868 $0
Q2 2022 Jul 26, 2022	SELL	$186.4 - $279.02 $11,184 - $16,741	-60 Reduced 5.3%	1,073 $234,000
Q1 2022 Apr 12, 2022	SELL	$194.8 - $275.7 $44,024 - $62,308	-226 Reduced 16.63%	1,133 $302,000
Q4 2021 Jan 18, 2022	BUY	$255.32 - $318.29 $346,979 - $432,556	1,359 New	1,359 $362,000

687

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.9B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.